Finally, we show that loss of both CCM2 and CCM3 also increases tyrosine phosphorylation of VEGFR2, suggesting that VEGFR2 activation may be a common mechanism that enhances the severity of CCM formation. The gene discussed is CCM2; the disease is cerebral cavernous malformation.